Myojo, Nissin enter capital tie-up talks

Myojo, Nissin enter capital tie-up talks

TOKYO, Japan - Photo shows a building housing Myojo Foods Co. in Tokyo. The Japanese instant-noodle maker has entered talks with industry leader Nissin Food Products Co. on a possible capital tie-up in an attempt to counter a hostile takeover bid by a U.S. investment fund, company officials said Nov. 10.

  • Product Code
  • ILEA001119431
  • Registered date
  • 2006/11/10 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2006 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 780.43(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Unitika to leave textile business

    Unitika to leave textile business

    Photo taken Nov. 28, 2024, shows the building housing the headquarters of Japanese chemical firm Unitika Ltd. in Osaka, western Japan. The company, which started in 1889 as a textiles firm, has decided to pull out of that loss-making side to its business and instead focus on packaging film for food and other polymer products, sources close to the matter said the same day.
      Unitika to leave textile business

      Unitika to leave textile business

      Photo taken Nov. 28, 2024, shows the building housing the headquarters of Japanese chemical firm Unitika Ltd. in Osaka, western Japan. The company, which started in 1889 as a textiles firm, announced the same day its decision to pull out of that loss-making side to its business and instead focus on packaging film for food and other polymer products.
        Seven-Eleven convenience store outlet

        Seven-Eleven convenience store outlet

        Photo taken on Nov. 26, 2024, shows a Seven-Eleven convenience store outlet in New York operated by Japan's Seven & i Holdings Co. Canada's Alimentation Couche-Tard Inc., the operator of the Circle K convenience stores, has made a takeover bid for its Japanese rival.
          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                Harris meets Japanese chip industry representatives

                Harris meets Japanese chip industry representatives

                U.S. Vice President Kamala Harris (C, background) holds talks with representatives of Japanese semiconductor-related companies at the official residence of the U.S. ambassador to Japan in Tokyo on Sept. 28, 2022. (Pool photo)
                  Takeda to sell nonprescription drug unit to Blackstone

                  Takeda to sell nonprescription drug unit to Blackstone

                  Photo taken Aug. 24, 2020, in Tokyo shows the global headquarters building of Takeda Pharmaceutical Co. The company said the same day it will sell its over-the-counter medicine unit Takeda Consumer Healthcare Co. for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.
                    Takeda to sell nonprescription drug unit to Blackstone

                    Takeda to sell nonprescription drug unit to Blackstone

                    Photo taken Aug. 24, 2020, in Tokyo shows the global headquarters building of Takeda Pharmaceutical Co. The company said the same day it will sell its over-the-counter medicine unit Takeda Consumer Healthcare Co. for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.
                      Ajinomoto to buy U.S. frozen foods maker Windsor

                      Ajinomoto to buy U.S. frozen foods maker Windsor

                      TOKYO, Japan - Masatoshi Ito (R), president of Ajinomoto Co., and Greg Geib, president of Windsor Quality Holdings, shake hands during a press conference in Tokyo on Sept. 10, 2014. They announced that Japan's Ajinomoto will buy the U.S. frozen foods maker for about $800 million in a bid to grow its presence in the giant North American market.